Express Scripts
NASDAQ: ESRX
$92.33
-$3.47 (-3.6%)
Closing price December 20, 2018
24/7 Wall St. has identified nine solid companies that are on very stable ground but that just refuse to pay dividends to their shareholders.
Published:
A new report from UBS shows some serious changes made to the firm's Equity Focus list for March.
Published:
Source: ThinkstockAfter the markets closed Monday, Express Scripts Holding Company (NASDAQ: ESRX) reported its fourth-quarter financial results as $1.39 in earnings per share (EPS) and $26.31 billion...
Published:
Source: courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has made its quarterly filing with the Securities & Exchange Commission for its holdings as of December 31, 2014. For all...
Published:
Rite Aid has announced that it will acquire EnvisionRx for $2 billion from the private equity firm TPG Capital.
Published:
Tuesday after the U.S. markets close, Gilead Sciences will report its fourth-quarter financial results.
Published:
Wednesday's top analyst upgrades, downgrades and initiations include AOL, Caterpillar, Goodyear, Southwest Airlines, Synchrony and Yahoo.
Published:
Gilead Sciences was picked up by Anthem to provide its hepatitis C drug as the primary option for patients.
Published:
Is it possible that Gilead Sciences is already coming back into favor after just a week of being in the doghouse?
Published:
Analysts are beginning to make their calls for what the future will hold for Gilead Sciences, AbbVie and Express Scripts.
Published:
AbbVie and Express Scripts have entered into an exclusive agreement under which Express Scripts will distribute AbbVie's hepatitis treatment.
Published:
Source: courtesy of WhiteHouse.govBerkshire Hathaway Inc. (NYSE: BRK-A) has released its public equity holdings as of September 30, 2014. Warren Buffett’s portfolio has recently undergone some...
Published:
Diplomat Pharmacy priced its IPO shares at $13 on Thursday, but when the stock began trading Friday morning it opened at $16.
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations covered by 24/7 Wall St. on Thursday, September 11, 2014.
Published:
Walgreen has decided to maintain its U.S. home, disappointing some big investors but very likely dodging a nasty reaction from U.S. consumers and the federal government.
Published:
Last Updated: